Hua Li
Academic / Other · 5 registered clinical trials — 3 currently recruiting.
| Status | Trial | Phase | Started |
|---|---|---|---|
| Not Yet Recruiting | Icariin Soft Capsules Combined With TACE as Adjuvant Therapy for HCC Hepatocarcinoma | Phase 2 | 2025-03-30 |
| Recruiting | Ablation in Combination With Lenvatinib and Anti-PD-1 Antibodies Hepatocellular Carcinoma | Phase 1 | 2024-01-01 |
| Recruiting | Clinical Study of Individualized Treatment of Relapsed or Drug-resistant Advanced Gynecological Tumors Guided Personalized Cancer Treatment | — | 2023-09-01 |
| Unknown | Combined Therapy Using D-TACE, Gemcitabine and Cisplatin, and PD1 Antibody in Advanced and Unresectable Intrah Unresectable Intrahepatic Cholangiocarcinoma | Phase 2 | 2023-06-30 |
| Unknown | Medroxyprogesterone Acetate vs LNG-IUS in Early-stage Endometrioid Carcinoma and Atypical Hyperplasia Patients Fertility Sparing | Phase 2 / Phase 3 | 2022-11-01 |